ADHD

There are estimates that the number of children with Attention Deficit Disorder (ADHD) in the United States ranges from three million to five million. The realization that children with ADHD continue to manifest the same problems as adults has created a further awareness of a substantial adult population that potentially could benefit from treatment. There are an estimated 8 to 10 million adults with adult ADHD in the United States. Currently fewer than 150,000 are being treated. In total this represents a patient pool of 11-15 million individuals. Based on its biomarker technology, Curemark estimates that, potentially, a substantial amount of the total ADHD population may benefit from
CM-ADHD.